AFT Pharmaceuticals Limited (NZE: AFT)
New Zealand
· Delayed Price · Currency is NZD 2.950
+0.020 (0.68%)
Jan 7, 2025, 9:59 AM NZST
AFT Pharmaceuticals Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 6, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 307 | 328 | 363 | 378 | 518 | 353 | Upgrade
|
| Market Cap Growth | -6.10% | -9.54% | -4.00% | -26.99% | 46.56% | 81.50% | Upgrade
|
| Enterprise Value | 330 | 363 | 395 | 414 | 556 | 397 | Upgrade
|
| Last Close Price | 2.93 | 3.11 | 3.43 | 3.58 | 4.91 | 3.60 | Upgrade
|
| PE Ratio | 28.81 | 21.03 | 34.06 | 19.04 | 68.17 | 30.20 | Upgrade
|
| Forward PE | 20.25 | 19.40 | 19.12 | 18.43 | 30.80 | 27.90 | Upgrade
|
| PS Ratio | 1.68 | 1.68 | 2.32 | 2.90 | 4.58 | 3.35 | Upgrade
|
| PB Ratio | 3.67 | 3.74 | 4.95 | 6.07 | 14.15 | 20.47 | Upgrade
|
| P/TBV Ratio | 12.41 | 4.60 | 6.35 | 8.16 | 24.65 | - | Upgrade
|
| P/FCF Ratio | 12.02 | 11.42 | 31.74 | 27.34 | 787.96 | 23.89 | Upgrade
|
| P/OCF Ratio | 13.16 | 11.37 | 31.20 | 26.71 | 690.25 | 23.74 | Upgrade
|
| PEG Ratio | 0.99 | 0.54 | 1.61 | 0.38 | 0.30 | - | Upgrade
|
| EV/Sales Ratio | 1.66 | 1.86 | 2.52 | 3.18 | 4.92 | 3.76 | Upgrade
|
| EV/EBITDA Ratio | 15.96 | 14.74 | 19.89 | 20.04 | 50.70 | 33.77 | Upgrade
|
| EV/EBIT Ratio | 17.20 | 14.98 | 20.10 | 20.31 | 51.92 | 34.55 | Upgrade
|
| EV/FCF Ratio | 12.91 | 12.63 | 34.58 | 29.96 | 846.29 | 26.88 | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.37 | 0.52 | 0.65 | 1.15 | 2.74 | Upgrade
|
| Debt / EBITDA Ratio | 1.63 | 1.27 | 1.85 | 1.90 | 3.61 | 3.79 | Upgrade
|
| Debt / FCF Ratio | 1.32 | 1.12 | 3.33 | 2.93 | 64.26 | 3.19 | Upgrade
|
| Asset Turnover | 1.29 | 1.25 | 1.14 | 1.12 | 1.18 | 1.40 | Upgrade
|
| Inventory Turnover | 2.15 | 2.34 | 2.20 | 2.04 | 2.28 | 2.39 | Upgrade
|
| Quick Ratio | 1.21 | 1.15 | 1.12 | 1.30 | 1.01 | 1.15 | Upgrade
|
| Current Ratio | 2.72 | 2.30 | 2.38 | 2.67 | 2.12 | 2.20 | Upgrade
|
| Return on Equity (ROE) | 14.40% | 19.38% | 15.72% | 40.14% | 28.91% | 113.60% | Upgrade
|
| Return on Assets (ROA) | 7.82% | 9.67% | 8.93% | 10.96% | 6.96% | 9.54% | Upgrade
|
| Return on Capital (ROIC) | 10.33% | 13.10% | 11.48% | 14.03% | 9.34% | 12.92% | Upgrade
|
| Earnings Yield | 3.47% | 4.76% | 2.94% | 5.25% | 1.50% | 3.59% | Upgrade
|
| FCF Yield | 8.32% | 8.76% | 3.15% | 3.66% | 0.13% | 4.19% | Upgrade
|
| Dividend Yield | 0.55% | 0.51% | 0.32% | - | - | - | Upgrade
|
| Payout Ratio | 14.46% | 7.39% | - | - | 2.42% | 4.46% | Upgrade
|
| Buyback Yield / Dilution | -56.43% | -0.02% | -0.16% | -1.34% | -6.15% | -0.00% | Upgrade
|
| Total Shareholder Return | -55.89% | 0.50% | 0.16% | -1.34% | -6.15% | -0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.